Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms

Japanese Journal of Infectious Diseases

Volumn 65, Issue 2, 2012, Pages 138-145

  Zhao, Haiyang ^a   Nakamura, Keiji ^a   Kohda, Tomoko ^a   Mukamoto, Masafumi ^a   Kozaki, Shunji ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MONOCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAVY CHAIN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIGHT CHAIN; MOUSE; NONHUMAN; RECOGNITION; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTITOXINS; BOTULINUM TOXINS, TYPE A; EPITOPES; IMMUNOPRECIPITATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; SEQUENCE ALIGNMENT;

EID: 84859035770     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Krieglstein, K.G., Dasgupta, B.R. and Henschen, A.H. (1994): Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of Ctermini of light and heavy chains. J. Protein Chem., 13, 49-57.
2. Swaminathan, S. and Eswaramoorthy, S. (2000): Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol., 7, 693-699.
3. Kozaki, S., Kamata, Y., Nagai, T., et al. (1986): The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Infect. Immun., 57, 786-791.
4. Sagane, Y., Watanabe, T., Kouguchi H., et al. (2002): Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex. Biochem. Biophys. Res. Commun., 292, 434-440.
5. Inoue, K., Fujinaga, Y., Watanabe, T., et al. (1996): Molecular composition of Clostridium botulinum type A progenitor toxins. Infect. Immun., 64, 1589-1594.
6. Ohishi, I., Sugii, S. and Sakaguchi, G. (1977): Oral toxicities of Clostridium botulinum toxins in response to molecular size. Infect. Immun., 16, 107-109.
7. Arndt, J.W., Gu, J., Jaroszewski, L., et al. (2005): The structure of the neurotoxin-associated protein HA33/A from Clostridium botulinum suggests a reoccurring beta-trefoil fold in the progenitor toxin complex. J. Mol. Biol., 346, 1083-1093.
8. Borden, L.D., William, T., Alona, C.C., et al. (1998): Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol., 5, 898-902.
9. Borden, L.D. and Raymond, C.S. (1999): Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol., 291, 1091-1104.
10. Hasegawa, K., Watanabe, T., Suzuki, T., et al. (2007): A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms. J. Biol. Chem., 282, 24777-24783.
11. Nakamura, T., Kotani, M., Tonozuka, T., et al. (2009): Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin. J. Mol. Biol., 385, 1193-1206.
12. Arndt, J.W., Jacobson, M.J., Abola, E.E., et al. (2006): A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J. Mol. Biol., 362, 733-742.
13. Dover, N., Barash, J.R. and Arnon, S.S. (2009): Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J. Clin. Microbiol., 47, 2349-2350.
14. Hill, K.K., Smith, T.J., Helma, C.H., et al. (2007): Genetic diversity among botulinum neurotoxin producing clostridial strains. J. Bacteriol., 189, 818-832.
15. Kozaki, S., Nakaue, S. and Kamata, Y. (1995): Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan. Microbiol. Immunol., 39, 767-774.
16. Smith, T.J., Lou, J., Geren, I.N., et al. (2005): Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun., 73, 5450-5457.
17. Torii, Y., Kiyota, N., Sugimoto, N., et al. (2011): Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test. Toxicon, 57, 93-99.
18. Sugii, S. and Sakaguchi, G. (1975): Molecular construction of Clostridium botulinum type A toxins. Infect. Immun., 12, 1262-1270.
19. Kozaki, S., Sakaguchi, S. and Sakaguchi, G. (1974): Purification and some properties of progenitor toxins of Clostridium botulinum type B. Infect. Immun., 10, 750-756.
20. Kozaki, S., Miki, A., Kamata, Y., et al. (1989): Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes. Infect. Immun., 57, 2634-2639.
21. Orlandi, R., Gussow, D.H., Jones, P.T., et al. (1989): Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 86, 3833-3837.
22. Laemmli, U.K. (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
23. Bradford, M.M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
24. Lowry, O.H., Rosebrough, N.J., Farr, A.L., et al. (1951): Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
25. Adekar, S.P., Takahashi, T., Jones, R.M., et al. (2008): Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain. PLoS ONE, 3, e3023.
26. Mullaney, B.P., Pallavicini, M.G. and Marks, J.D. (2001): Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display. Infect. Immun., 69, 6511-6514.
27. Chen, F., Kuziemko, G.M., Amersdorfer, P., et al. (1997): Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms. Infect. Immun., 65, 1626-1630.
28. Eisele, K., Fink, K., Vey, M., et al. (2011): Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon, 57, 555-565.